Consumption of antihypertensive drugs dispensed under the pharmacy benefit management program

Authors

  • Aline Pereira Rocha Municipal University of São Caetano do Sul; School of Pharmacy
  • Brigitte Rieckmann Martins dos Santos Municipal University of São Caetano do Sul; School of Pharmacy

DOI:

https://doi.org/10.1590/S1984-82502011000400018

Keywords:

Hypertension, Antihypertensive drugs, Drugs^i1^scontinuous, Antihypertensive medications^i1^s, Treatment adherence, Drug therapy^i1^sadherence to treatm, Medicines^i1^sbenefit manegem

Abstract

Pharmacy benefit management (PBM) programs provide attractive discounts for drug purchase, a relevant measure to address costs, mainly of drugs for the treatment of chronic diseases. This study investigated whether PBM may be used as a tool to provide information about the use of antihypertensive medications when they are purchased. The profile of medicines taken to treat high blood pressure by large IT company employees and their dependents was evaluated from January to December 2009. The mean rate of drug boxes purchased to control hypertension was 9.4 ± 10.0 in 2009. Men purchased more drugs than women. The number of drugs purchased for the treatment of hypertension was lower than expected in all age groups except for individuals aged 54-58 and >;59 years. Among men, the purchase of drugs to treat hypertension was higher than expected in the 24-28, 34-38 and 54-58 age groups. Among women, results matched expectations, except for the age group 34-38 years, in which purchase was lower than expected. Individuals in the age group 0-18 years were found to consume antihypertensive drugs. Although the PBM system may be used to identify drugs purchased by users, it does not ensure patient adherence to recommended drug treatment to control hypertension.

Downloads

Download data is not yet available.

Downloads

Published

2011-12-01

Issue

Section

Articles

How to Cite

Consumption of antihypertensive drugs dispensed under the pharmacy benefit management program . (2011). Brazilian Journal of Pharmaceutical Sciences, 47(4), 807-815. https://doi.org/10.1590/S1984-82502011000400018